数据驱动的分子类型:食道癌症管理的新前沿
Yue Du1, Bianli Gu1, Linlin Shi1
1Henan Key Laboratory of Microbiome and Esophageal Cancer Prevention and Treatment, Henan Key Laboratory of Cancer Epigenetics, The First Affiliated Hospital (College of Clinical Medicine) of Henan University of Science and Technology, Cancer Hospital, Luoyang, Henan, China.
Cancer medicine
|February 28, 2025
概括
使用多omics数据的食道状细胞癌 (ESCC) 的分子亚型化揭示了不同的亚型. 这些亚型为个性化癌症治疗提供了新的生物标志物和治疗点.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
背景情况:
- 食道状细胞癌 (ESCC) 是一种致命的癌症,存活率很低.
- 晚期诊断限制了大多数ESCC患者的治疗选择.
- 多omics整合已经确定了ESCC的独特分子亚型.
研究的目的:
- 系统地审查ESCC中分子亚型的当前状态.
- 总结ESCC亚型与不同的治疗反应和预后.
- 突出基于omics的亚型化对ESCC管理的临床影响.
主要方法:
- 在ESCC中对大数据驱动的分子亚型研究进行系统审查.
- 整合多omics数据 (基因组学,转录组学,蛋白质组学,代谢组学,单细胞测序).
- 分析亚型特定的遗传变化,信号通路和代谢特征.
主要成果:
- 识别具有独特特征的独特ESCC分子亚型.
- 发现亚型特异性突变,途径改变和代谢特征.
- 建立了分子亚型,免疫疗法,化疗反应和药物开发之间的联系.
结论:
- 基于Omics的分子排型为ESCC异质性提供了关键的见解.
- 分子亚型化可以作为开发新生物标志物和治疗点的基础.
- 对ESCC的个性化治疗策略可以通过分子亚型化来促进.
相关概念视频
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...


